Squarepoint’s BioLife Solutions BLFS Stock Holding History

Squarepoint’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.75M	Buy	+132,942	New	+$3.11M	﹤0.01%	1820
2025 Q4	–	Sell	-54,633	Closed	-$1.39M	–	4287
2025 Q3	$1.39M	Sell	54,633 -14,176	-21%	-$336K	﹤0.01%	2392
2025 Q2	$1.48M	Buy	+68,809	New	+$1.55M	﹤0.01%	2321
2024 Q4	–	Sell	-31,598	Closed	-$791K	–	5030
2024 Q3	$791K	Sell	31,598 -16,998	-35%	-$401K	﹤0.01%	2781
2024 Q2	$1.04M	Buy	+48,596	New	+$943K	﹤0.01%	2523
2024 Q1	–	Sell	-52,980	Closed	-$861K	–	4046
2023 Q4	$861K	Buy	52,980 +41,854	+376%	+$534K	﹤0.01%	2629
2023 Q3	$154K	Buy	+11,126	New	+$175K	﹤0.01%	3480
2022 Q1	–	Sell	-25,816	Closed	-$962K	–	2841
2021 Q4	$962K	Buy	+25,816	New	+$1.11M	﹤0.01%	1722
2021 Q2	–	Sell	-24,865	Closed	-$895K	–	3238
2021 Q1	$895K	Buy	+24,865	New	+$983K	0.01%	1599
2020 Q3	–	Sell	-19,295	Closed	-$315K	–	2496
2020 Q2	$315K	Sell	19,295 -33,447	-63%	-$461K	0.01%	1570
2020 Q1	$501K	Buy	+52,742	New	+$724K	0.01%	1041

Other funds holding BLFS

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Squarepoint's BLFS Position: Q2 2026 in Review

Squarepoint opened a new position in BioLife Solutions (BLFS) in Q2 2026: 132,942 shares worth $3.75M. The stake represents ﹤0.01% of the portfolio and ranks #1820 among its holdings. This is a return to the name: Squarepoint previously reported a position in BLFS as recently as Q3 2025.

Squarepoint first reported a position in BLFS in Q1 2020 and has held it in 11 quarters since. 217 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

Squarepoint held 132,942 shares of BioLife Solutions worth $3.75M as of Q2 2026.
BioLife Solutions was a new Squarepoint position in Q2 2026.
BioLife Solutions made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #1820 holding.
Squarepoint first reported a position in BioLife Solutions in Q1 2020 and has held it in 11 quarters since.
217 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.